[EN] LOFEXIDINE ENANTIOMERS FOR USE AS A TREATMENT FOR CNS DISEASE AND PATHOLOGIES AND ITS CHIRAL SYNTHESIS<br/>[FR] ÉNANTIOMÈRES DE LOFEXIDINE EN VUE D'UNE UTILISATION EN TANT QUE TRAITEMENT DE MALADIE ET DE PATHOLOGIES DU SYSTÈME NERVEUX CENTRAL ET SA SYNTHÈSE CHIRALE
申请人:AGEAN LLC
公开号:WO2010016844A1
公开(公告)日:2010-02-11
The invention relates to methods for treatment of CNS disease and pathologies using non-racemic mixtures of lofexidine enantiomers. The invention also relates to processes for the manufacture of chirally pure enantiomers of lofexidine.
Lofexidine enantiomers for use as a treatment for CNS disease and pathologies and its chiral synthesis
申请人:Digenis George
公开号:US20080319041A1
公开(公告)日:2008-12-25
The invention relates to methods for treatment of CNS disease and pathologies using non-racemic mixtures of lofexidine enantiomers. The invention also relates to processes for the manufacture of chirally pure enantiomers of lofexidine.
[EN] PROCESS FOR THE SYNTHESIS OF LOFEXIDINE<br/>[FR] PROCÉDÉ DE SYNTHÈSE DE LOFEXIDINE
申请人:MEDICHEM SA
公开号:WO2021209617A1
公开(公告)日:2021-10-21
The present invention relates to an improved process for the synthesis of lofexidine, or a pharmaceutically acceptable salt thereof, using an aluminium alkoxide as Lewis acid.